ROMA; RISK OF OVARIAN MALIGNANCY ALGORITHM
Risk of Ovarian Malignancy algorithm (ROMA) test is used as an aid in assessing the risk of Ovarian cancer in women with a pelvic mass based on patient’s HE4 & CA125 levels and their menopausal status. Women with ROMA levels above their cutoff have an increased risk of Ovarian cancer. ROMA must be interpreted in conjunction with clinical & radiological assessment.
Parameter(s) covered : 4
Report Frequency: Sample Mon / Thu by 4 pm; Report Same day
Special Instruction: Provide menopausal status of the patient.
Price : ₹ 3200.00
Parameters
- HE4 ( HUMAN EPIDIDYMIS PROTEIN 4) , SERUM
- ROMA (Post menopausal)
- ROMA (Premenopausal)
- CA125